Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. ALK-Abello, Inc.
FDA Inspection
•ALK-Abello, Inc.•March 1, 2019

ALK-Abello, Inc. – FDA Inspection, Mar 1, 2019

Record Details

This FDA Inspection record concerns ALK-Abello, Inc., with an inspection on March 1, 2019, issued by the New England District Office, covering human drugs.

Company
ALK-Abello, Inc.
Inspection Date
March 1, 2019
Product Type
Human Drugs
Office
New England District Office
People
  • Erik W. Koester (FDA Associated Person)
  • Jonah S. Ufferfilge (FDA Associated Person)
  • Sean R. Marcsisin (FDA Associated Person)
View Company Profile

ID · 661aa8fb-09cc-4bd8-8ed0-7617aa8aa111

Inspection Facts

Inspection number
1080880
FDA center
Human Drugs
Project area
New Drug Evaluation
Outcome
Form 483 issued

FDA Citations

15
  1. 21 CFR 211.100(a)Absence of Written Procedures
  2. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  3. 21 CFR 211.113(b)Procedures for sterile drug products
  4. 21 CFR 211.150Written distribution procedure
  5. 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
  6. 21 CFR 211.166(a)Written program not followed
  7. 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
  8. 21 CFR 211.192Investigations of discrepancies, failures
  9. 21 CFR 211.22(d)Procedures not in writing, fully followed
  10. 21 CFR 211.25(a)Training , Education , Experience overall

Showing 10 of 15 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of ALK-Abello, Inc.

9
DateClassificationOfficeProject area
June 13, 2025OAINew England District OfficeDrug Quality Assurance
October 21, 2022OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 3, 2021OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 29, 2018NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
September 19, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 9 other inspections on the company page
Other documents for ALK-Abello, Inc.
  • FDA Inspection 1272585 - 2025-06-13
  • FDA Inspection 1181903 - 2022-10-21
  • FDA Inspection 1141073 - 2021-05-03
  • FDA Inspection 1073636 - 2018-11-29
  • FDA Inspection 1025749 - 2017-09-19

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore ALK-Abello, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.